Skip to content

Released Nov 9, 2011

10-Q filed Nov 9, 2011, 40 days after period end · 0001104659-11-062735

Q3 2011 · 10-Q
Revenue$12.22M+34.9% vs Q3 2010+8.5% vs Q2 2011
Net Income-$20.63MN/M vs Q3 2010N/M vs Q2 2011
EPS Diluted-$0.21N/M vs Q3 2010N/M vs Q2 2011
Operating Income-$21,616,000N/M
Operating Cash Flowderived-$25,415,000N/M
Free Cash Flowderived-$25,981,000N/M
Margins · derived
Operating margin-176.9%+1.5 pt vs Q3 2010
Net margin-168.9%−94.4 pt vs Q3 2010

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2011Q3 2010
Revenue$12.22M$9.06M
Net Income-$20.63M-$6.75M
EPS Diluted-$0.21-$0.08

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR